The activation and inhibition of cyclin-dependent kinase-5 by phosphorylation
- PMID: 17713927
- DOI: 10.1021/bi700890t
The activation and inhibition of cyclin-dependent kinase-5 by phosphorylation
Abstract
Despite the very similar 3-dimensional structures as reflected by the more than 60% identity in amino acid sequences, CDK2 and CDK5 have very different functions and characteristics. Phosphorylation on a conserved Thr14 can inhibit activities of both the kinases, but phosphorylating another conserved Tyr15, however, can lead to totally opposite inhibition and stimulation consequences in CDK2 and CDK5. Our molecular dynamics (MD) simulations suggest a similar inhibition mechanism of phosphorylation on the Thr14 as in the CDK2 system. In both the systems, the kinase activities are inhibited by the phosphorylation because it causes ATP phosphate moiety misalignment and changes in the Mg2+ ion coordination sphere, which have been proven to be critical for the phosphate group of the ATP transferring to the hydroxyl group on the serine in the substrate peptide. The calculations indicate that ATP adopts a more favorable conformation and location in the phosphorylated Tyr15 complex to facilitate the interactions with the substrate and the Mg2+ is wrapped more strongly by the phosphate group than in the unphosphorylated system, which might be favored by the transfer reaction.
Similar articles
-
Regulatory phosphorylation of cyclin-dependent kinase 2: insights from molecular dynamics simulations.J Mol Model. 2008 Aug;14(8):761-8. doi: 10.1007/s00894-008-0312-1. Epub 2008 May 10. J Mol Model. 2008. PMID: 18470542
-
The mechanism of inhibition of the cyclin-dependent kinase-2 as revealed by the molecular dynamics study on the complex CDK2 with the peptide substrate HHASPRK.Protein Sci. 2005 Feb;14(2):445-51. doi: 10.1110/ps.04959705. Epub 2005 Jan 4. Protein Sci. 2005. PMID: 15632290 Free PMC article.
-
Role of phosphorylated Thr160 for the activation of the CDK2/Cyclin A complex.Proteins. 2006 Jan 1;62(1):89-98. doi: 10.1002/prot.20697. Proteins. 2006. PMID: 16292742
-
Activation and inhibition of cyclin-dependent kinase-2 by phosphorylation; a molecular dynamics study reveals the functional importance of the glycine-rich loop.Protein Sci. 2004 Jun;13(6):1449-57. doi: 10.1110/ps.03578504. Epub 2004 May 7. Protein Sci. 2004. PMID: 15133164 Free PMC article.
-
A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator.Biochem Biophys Res Commun. 1999 Jun 7;259(2):420-8. doi: 10.1006/bbrc.1999.0792. Biochem Biophys Res Commun. 1999. PMID: 10362524
Cited by
-
c-Abl Inhibition Exerts Symptomatic Antiparkinsonian Effects Through a Striatal Postsynaptic Mechanism.Front Pharmacol. 2018 Nov 16;9:1311. doi: 10.3389/fphar.2018.01311. eCollection 2018. Front Pharmacol. 2018. PMID: 30505273 Free PMC article.
-
Molecular basis of differential selectivity of cyclobutyl-substituted imidazole inhibitors against CDKs: insights for rational drug design.PLoS One. 2013 Sep 13;8(9):e73836. doi: 10.1371/journal.pone.0073836. eCollection 2013. PLoS One. 2013. PMID: 24058495 Free PMC article.
-
Marine-Derived Compounds for CDK5 Inhibition in Cancer: Integrating Multi-Stage Virtual Screening, MM/GBSA Analysis and Molecular Dynamics Investigations.Metabolites. 2023 Oct 18;13(10):1090. doi: 10.3390/metabo13101090. Metabolites. 2023. PMID: 37887415 Free PMC article.
-
Molecular cloning, sequence characterization and tissue transcription profile analyses of two novel genes: LCK and CDK2 from the Black-boned sheep (Ovis aries).Mol Biol Rep. 2010 Jan;37(1):39-45. doi: 10.1007/s11033-009-9532-4. Epub 2009 Apr 2. Mol Biol Rep. 2010. PMID: 19340603
-
CDK5: Insights into its roles in diseases.Mol Biol Rep. 2025 Jan 21;52(1):145. doi: 10.1007/s11033-025-10253-4. Mol Biol Rep. 2025. PMID: 39836243 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases